Thulium-167 Market Share Driven by Advancements in Medical Imaging and Radiotherapy | Valuates Reports

Thulium-167 Market Size
The global market for Thulium-167 was valued at US$ 8.3 million in the year 2024 and is projected to reach a revised size of US$ 14.4 million by 2031, growing at a CAGR of 7.9% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-24N18963/Global_Thulium_170_Market_Research_Report_2025

The Thulium-167 market is experiencing significant growth, driven by its increasing application in medical imaging, radiotherapy, and scientific research. This radioisotope, produced through nuclear reactors and accelerators, is gaining prominence due to its unique properties that make it suitable for targeted therapies and diagnostic procedures. The market is witnessing a surge in demand as healthcare providers seek advanced solutions for precise treatment delivery and enhanced imaging capabilities.

In terms of production methods, the segment utilizing nuclear reactors currently holds a substantial market share. This approach has been the traditional method for producing medical isotopes, including Thulium-167. However, the accelerator-based production method is rapidly gaining traction. Accelerators offer the advantage of producing isotopes without the need for uranium enrichment, aligning with growing concerns over nuclear proliferation and waste management. This shift towards accelerator-based production is expected to contribute to the market's expansion.

The application of Thulium-167 spans several critical areas. Medical imaging is a leading application, where the isotope's properties facilitate high-resolution imaging, aiding in accurate diagnosis and treatment planning. Radiotherapy is another significant application, with Thulium-167 being used in targeted therapies that minimize damage to surrounding healthy tissues. Additionally, scientific research applications are exploring the use of Thulium-167 for various experimental purposes, further driving its demand across different sectors.

Key players in the Thulium-167 market include renowned institutions such as CERN, the Paul Scherrer Institute, Oak Ridge National Laboratory, Los Alamos National Laboratory, and SCK CEN. These organizations are at the forefront of research and development in the field, contributing to advancements in production techniques and expanding the applications of Thulium-167. Their efforts are instrumental in meeting the growing demand for this isotope and ensuring its availability for medical and research purposes.

Regionally, North America leads the Thulium-167 market, owing to its advanced healthcare infrastructure and significant investments in medical research. Europe follows closely, with countries like Germany, France, and the UK playing pivotal roles in the development and application of Thulium-167. The Asia-Pacific region, particularly China and Japan, is witnessing rapid growth in the market, driven by increasing healthcare needs and technological advancements. As the global demand for Thulium-167 continues to rise, innovations in production methods and applications are expected to shape the future of this market, ensuring its pivotal role in medical and scientific advancements.

Segment by Type

• Produced by Nuclear Reactor
• Produced by Accelerator

Segment by Application

• Medical Imaging
• Radiotherapy
• Scientific Research

By Company

CERN, Paul Scherrer Institute, Oak Ridge National Laboratory, Los Alamos National Laboratory, SCK CEN

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-24N18963/global-thulium-170

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.